Does stage of illness influence recovery-focused outcomes after psychological treatment in bipolar disorder? A systematic review protocol

Systematic Reviews

Volumn 8, Issue 1, 2019, Pages

  Tremain, Hailey ^a   Fletcher, Kathryn ^a   Scott, Jan ^a,b   McEnery, Carla ^a,d,e   Berk, Michael ^c,d,e,f   Murray, Greg ^a  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c DEAKIN UNIVERSITY   (Australia)

^d THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Bipolar disorder; Clinical staging; Functioning; Moderator; Psychosocial interventions; Psychotherapy; Quality of life; Recovery; Stage of illness; Treatment

Indexed keywords

BIPOLAR DISORDER; CLINICIAN; COGNITION; COGNITIVE BEHAVIORAL THERAPY; CONSUMER; FUNCTIONAL ASSESSMENT; ICD-10; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; PSYCHOEDUCATION; QUALITY OF LIFE; REVIEW; SCIENTIST; SYSTEMATIC REVIEW; CONVALESCENCE; HUMAN; PATIENT ACUITY; PROCEDURES; PSYCHOLOGY; PSYCHOSOCIAL REHABILITATION; PSYCHOTHERAPY;

BIPOLAR DISORDER; COGNITION; HUMANS; OUTCOME ASSESSMENT, HEALTH CARE; PATIENT ACUITY; PSYCHIATRIC REHABILITATION; PSYCHOTHERAPY; QUALITY OF LIFE; RECOVERY OF FUNCTION; SYSTEMATIC REVIEWS AS TOPIC;

EID: 85066415072     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/s13643-019-1042-4     Document Type: Review

References (104)

1. Duffy A, Horrocks J, Doucette S, Keown-Stoneman C, McCloskey S, Grof P. The developmental trajectory of bipolar disorder. Br J Psychiatry. 2014. https://doi.org/10.1192/bjp.bp.113.126706.
2. Berk M, Berk L, Dodd S, Cotton S, Macneil C, Daglas R, Conus P, Bechdolf A, Moylan S, Malhi GS. Stage managing bipolar disorder. Bipolar Disord. 2014. https://doi.org/10.1111/bdi.12099.
3. Post RM, Fleming J, Kapczinski F. Neurobiological correlates of illness progression in the recurrent affective disorders. J Psychiatr Res. 2012. https://doi.org/10.1016/j.jpsychires.2012.02.004.
4. Vieta E, Reinares M, Rosa AR. Staging bipolar disorder. Neurotox Res. 2011. https://doi.org/10.1007/s12640-010-9197-8.
5. Rosa AR, Magalhaes PV, Czepielewski L, Sulzbach MV, Goi PD, Vieta E, Gama CS, Kapczinski F. Clinical staging in bipolar disorder: focus on cognition and functioning. J Clin Psychiatry. 2014. https://doi.org/10.4088/JCP.13m08625.
6. Scott J, Leboyer M, Hickie I, Berk M, Kapczinski F, Frank E, Kupfer D, McGorry P. Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. Br J Psychiatry. 2013. https://doi.org/10.1192/bjp.bp.112.110858.
7. McGorry PD, Nelson B, Goldstone S, Yung A. Clinical staging: a heuristic and practical strategy for new research and better health and social outcomes for psychotic and related mood disorders. Can J Psychiat-Rev Can Psychiat. 2010;55:486-97.
8. Berk M, Conus P, Lucas N, Hallam K, Malhi GS, Dodd S, Yatham LN, Yung A, McGorry P. Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord. 2007. https://doi.org/10.1111/j.1399-5618.2007.00484.x.
9. Kapczinski F, Dias VV, Kauer-Sant'Anna M, Frey BN, Grassi-Oliveira R, Colom F, Berk M. Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother. 2009. https://doi.org/10.1586/ern.09.31.
10. Alda M, Kapczinski F. Staging model raises fundamental questions about the nature of bipolar disorder. J Psychiatry Neurosci. 2016;41:291-3.
11. Frank E, Nimgaonkar VL, Phillips ML, Kupfer DJ. All the world's a (clinical) stage: rethinking bipolar disorder from a longitudinal perspective. Mol Psychiatry. 2015. https://doi.org/10.1038/mp.2014.71.
12. Fernandes BS, Berk M. Staging in bipolar disorder: one step closer to precision psychiatry. Rev Bras Psiquiatr. 2017. https://doi.org/10.1590/1516-4446-2017-3902.
13. Kapczinski F, Magalhaes PV, Balanza-Martinez V, Dias VV, Frangou S, Gama CS, Gonzalez-Pinto A, Grande I, Ha K, Kauer-Sant'Anna M, et al. Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force Report. Acta Psychiatr Scand. 2014. https://doi.org/10.1111/acps.12305.
14. Deckersbach T, Peters AT, Sylvia LG, Gold AK, da Silva Magalhaes PV, Henry DB, Frank E, Otto MW, Berk M, Dougherty DD, et al. A cluster analytic approach to identifying predictors and moderators of psychosocial treatment for bipolar depression: results from STEP-BD. J Affect Disord. 2016. https://doi.org/10.1016/j.jad.2016.03.064.
15. Grande I, Magalhaes PV, Chendo I, Stertz L, Panizutti B, Colpo GD, Rosa AR, Gama CS, Kapczinski F, Vieta E. Staging bipolar disorder: clinical, biochemical, and functional correlates. Acta Psychiatr Scand. 2014. https://doi.org/10.1111/acps.12268.
16. Kauer-Sant'Anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT, Yatham LN. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol. 2009. https://doi.org/10.1017/S1461145708009310.
17. Berk M, Hallam KT, McGorry PD. The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J Affect Disord. 2007. https://doi.org/10.1016/j.jad.2007.03.007.
18. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, Germano D, Bravin J, McDonald T, Blair A, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry. 2002;59:921-8.
19. Berk M, Berk L, Udina M, Moylan S, Stafford L, Hallam K, Goldstone S, McGorry PD. Palliative models of care for later stages of mental disorder: maximizing recovery, maintaining hope, and building morale. Aust N Z J Psychiatry. 2012. https://doi.org/10.1177/0004867411432072.
20. Murray G, Leitan ND, Thomas N, Michalak EE, Johnson SL, Jones S, Perich T, Berk L, Berk M. Towards recovery-oriented psychosocial interventions for bipolar disorder: quality of life outcomes, stage-sensitive treatments, and mindfulness mechanisms. Clin Psychol Rev. 2017. https://doi.org/10.1016/j.cpr.2017.01.002.
21. Goi PD, Bucker J, Vianna-Sulzbach M, Rosa AR, Grande I, Chendo I, Sodre LA, Kauer-Sant'Anna M, Silveira L, Kunz M, et al. Pharmacological treatment and staging in bipolar disorder: evidence from clinical practice. Braz J Psychiatry. 2015. https://doi.org/10.1590/1516-4446-2014-1554.
22. Colom F, Reinares M, Pacchiarotti I, Popovic D, Mazzarini L, Martinez-Aran A, Torrent C, Rosa A, Palomino-Otiniano R, Franco C, et al. Has number of previous episodes any effect on response to group psychoeducation in bipolar patients? A 5-year follow-up post hoc analysis. Acta Neuropsychiatr. 2010. https://doi.org/10.1111/j.1601-5215.2010.00450.x.
23. Passos IC, Mwangi B, Vieta E, Berk M, Kapczinski F. Areas of controversy in neuroprogression in bipolar disorder. Acta Psychiatr Scand. 2016. https://doi.org/10.1111/acps.12581.
24. Berk M, Brnabic A, Dodd S, Kelin K, Tohen M, Malhi GS, Berk L, Conus P, McGorry PD. Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord. 2011. https://doi.org/10.1111/j.1399-5618.2011.00889.x.
25. Joyce K, Thompson A, Marwaha S. Is treatment for bipolar disorder more effective earlier in illness course? A comprehensive literature review. Int J Bipolar Disord. 2016. https://doi.org/10.1186/s40345-016-0060-6.
26. Lavagnino L, Cao B, Mwangi B, Wu MJ, Sanches M, Zunta-Soares GB, Kapczinski F, Soares J. Changes in the corpus callosum in women with late-stage bipolar disorder. Acta Psychiatr Scand. 2015. https://doi.org/10.1111/acps.12397.
27. Tremain H, Fletcher K, Murray G. Number of episodes in bipolar disorder: the case for more thoughtful conceptualisation and measurement bipolar disorders (under review) 2019.
28. Nasrallah HA. Staging psychiatric disorders: a clinico-biologic model (from the editor). Curr Psychiatr Ther. 2013;12:9.
29. Reinares M, Papachristou E, Harvey P, Mar Bonnin C, Sanchez-Moreno J, Torrent C, Ayuso-Mateos JL, Ploubidis GB, Vieta E, Frangou S. Towards a clinical staging for bipolar disorder: defining patient subtypes based on functional outcome. J Affect Disord. 2013. https://doi.org/10.1016/j.jad.2012.06.005.
30. Reinares M, Colom F, Rosa AR, Bonnin CM, Franco C, Sole B, Kapczinski F, Vieta E. The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J Affect Disord. 2010. https://doi.org/10.1016/j.jad.2009.09.009.
31. Andreazza AC, Kapczinski F, Kauer-Sant'Anna M, Walz JC, Bond DJ, Goncalves CA, Young LT, Yatham LN. 3-nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J Psychiatry Neurosci. 2009;34:263-71.
32. Murray G, Leitan ND, Berk M, Thomas N, Michalak E, Berk L, Johnson SL, Jones S, Perich T, Allen NB, et al. Online mindfulness-based intervention for late-stage bipolar disorder: pilot evidence for feasibility and effectiveness. J Affect Disord. 2015. https://doi.org/10.1016/j.jad.2015.02.024.
33. Miziou S, Tsitsipa E, Moysidou S, Karavelas V, Dimelis D, Polyzoidou V, Fountoulakis KN. Psychosocial treatment and interventions for bipolar disorder: a systematic review. Ann General Psychiatry. 2015. https://doi.org/10.1186/s12991-015-0057-z.
34. Scott J, Paykel E, Morriss R, Bentall R, Kinderman P, Johnson T, Abbott R, Hayhurst H. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry. 2006. https://doi.org/10.1192/bjp.188.4.313.
35. Colom F, Vieta E, Martinez-Aran A, Reinares M, Goikolea JM, Benabarre A, Torrent C, Comes M, Corbella B, Parramon G, et al. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry. 2003. https://doi.org/10.1001/archpsyc.60.4.402.
36. Reinares M, Colom F, Sanchez-Moreno J, Torrent C, Martinez-Aran A, Comes M, Goikolea JM, Benabarre A, Salamero M, Vieta E. Impact of caregiver group psychoeducation on the course and outcome of bipolar patients in remission: a randomized controlled trial. Bipolar Disord. 2008. https://doi.org/10.1111/j.1399-5618.2008.00588.x.
37. Peters AT, Sylvia LG, Magalhaes PV, Miklowitz DJ, Frank E, Otto MW, Hansen NS, Dougherty DD, Berk M, Nierenberg AA, et al. Age at onset, course of illness and response to psychotherapy in bipolar disorder: results from the Systematic Treatment Enhancement Program For Bipolar Disorder (STEP-BD). Psychol Med. 2014. https://doi.org/10.1017/S0033291714000804.
38. Murray G. You say you want a revolution: recovery, biomedicine and muddling through. Aust N Z J Psychiatry. 2015. https://doi.org/10.1177/0004867415610200.
39. Bonnin CM, Torrent C, Arango C, Amann BL, Sole B, Gonzalez-Pinto A, Crespo JM, Tabares-Seisdedos R, Reinares M, Ayuso-Mateos JL, et al. Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome. Br J Psychiatry. 2016. https://doi.org/10.1192/bjp.bp.114.162123.
40. Torrent C, Bonnin Cdel M, Martinez-Aran A, Valle J, Amann BL, Gonzalez-Pinto A, Crespo JM, Ibanez A, Garcia-Portilla MP, Tabares-Seisdedos R, et al. Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry. 2013. https://doi.org/10.1176/appi.ajp.2012.12070971.
41. de Barros Pellegrinelli K, de OCLF, Silval KI, Dias VV, Roso MC, Bandeira M, Colom F, Moreno RA. Efficacy of psychoeducation on symptomatic and functional recovery in bipolar disorder. Acta Psychiatr Scand. 2013. https://doi.org/10.1111/acps.12007.
42. Smith DJ, Griffiths E, Poole R, di Florio A, Barnes E, Kelly MJ, Craddock N, Hood K, Simpson S. Beating bipolar: exploratory trial of a novel internet-based psychoeducational treatment for bipolar disorder. Bipolar Disord. 2011. https://doi.org/10.1111/j.1399-5618.2011.00949.x.
43. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018. https://doi.org/10.1111/bdi.12609.
44. Geddes JR, Miklowitz DJ. Treatment of bipolar disorder. Lancet (London, England). 2013. https://doi.org/10.1016/S0140-6736(13)60857-0.
45. Goodwin GM, Haddad PM, Ferrier IN, Aronson JK, Barnes T, Cipriani A, Coghill DR, Fazel S, Geddes JR, Grunze H, et al. Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2016. https://doi.org/10.1177/0269881116636545.
46. Oud M, Mayo-Wilson E, Braidwood R, Schulte P, Jones SH, Morriss R, Kupka R, Cuijpers P, Kendall T. Psychological interventions for adults with bipolar disorder: systematic review and meta-analysis. Br J Psychiatry. 2016. https://doi.org/10.1192/bjp.bp.114.157123.
47. Salcedo S, Gold AK, Sheikh S, Marcus PH, Nierenberg AA, Deckersbach T, Sylvia LG. Empirically supported psychosocial interventions for bipolar disorder: current state of the research. J Affect Disord. 2016. https://doi.org/10.1016/j.jad.2016.05.018.
48. Reinares M, Sanchez-Moreno J, Fountoulakis KN. Psychosocial interventions in bipolar disorder: what, for whom, and when. J Affect Disord. 2014. https://doi.org/10.1016/j.jad.2013.12.017.
49. Murray G. Adjunctive psychosocial interventions for bipolar disorder: some psychotherapeutic context for the Canadian Network for Mood and Anxiety Treatments (CANMAT) & International Society for Bipolar Disorders (ISBD) guidelines. Bipolar Disord. 2018. https://doi.org/10.1111/bdi.12655.
50. Lam DH, Burbeck R, Wright K, Pilling S. Psychological therapies in bipolar disorder: the effect of illness history on relapse prevention - a systematic review (report). Bipolar Disord. 2009;11:474.
51. Kupfer DJ, Frank E, Ritchey FC. Staging bipolar disorder: what data and what models are needed? Lancet Psychiatry. 2015; https://doi.org/10.1016/S2215-0366(15)00096-6.
52. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015. https://doi.org/10.1136/bmj.g7647.
53. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009. https://doi.org/10.1016/j.jclinepi.2009.06.006.
54. Faedda GL, Baldessarini RJ, Glovinsky IP, Austin NB. Pediatric bipolar disorder: phenomenology and course of illness. Bipolar Disord. 2004;6:305-13.
55. Levy B, Medina AM, Weiss RD. Cognitive and psychosocial functioning in bipolar disorder with and without psychosis during early remission from an acute mood episode: a comparative longitudinal study. Compr Psychiatry. 2013. https://doi.org/10.1016/j.comppsych.2012.12.018.
56. Jones SH, Thornicroft G, Coffey M, Dunn G. A brief mental health outcome scale: reliability and validity of the global assessment of functioning (gaf). Br J Psychiatry. 1995;166:654-9.
57. Rosa AR, Sanchez-Moreno J, Martinez-Aran A, Salamero M, Torrent C, Reinares M, Comes M, Colom F, Van Riel W, Ayuso-Mateos JL, et al. Validity and reliability of the functioning assessment short test (fast) in bipolar disorder. Clin Pract Epidemiol Ment Health. 2007. https://doi.org/10.1186/1745-0179-3-5.
58. Leon A, Solomon D, Mueller T, Turvey C, Endicott J, Keller M. The range of impaired functioning tool (life-rift): a brief measure of functional impairment. Psychol Med. 1999;29:869-78.
59. Organization WH. World Health Organization disabilty assessment schedule: WHODAS II. Phase 2 field trials. Health services research. 2000.
60. Arbuckle R, Frye MA, Brecher M, Paulsson B, Rajagopalan K, Palmer S, Degl'Innocenti A. The psychometric validation of the Sheehan Disability Scale (SDS) in patients with bipolar disorder. Psychiatry Res. 2009;165:163-74.
61. Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S. The social functioning scale the development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry. 1990;157:853-9.
62. Altshuler L, Mintz J, Leight K. The Life Functioning Questionnaire (LFQ): a brief, gender-neutral scale assessing functional outcome. Psychiatry Res. 2002. https://doi.org/10.1016/S0165-1781(02)00180-4.
63. Patterson TL, Goldman S, McKibbin CL, Hughs T, Jeste DV. UCSD performance-based skills assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull. 2001;27:235-45.
64. Aydemlr Ö, Eren İ, Savaş H, Oǧuzhanoǧlu NK, Kocal N, Özgüven HD, Akkaya C, Başterzl AD, Karlidaǧ R, Yenllmez Ç. Development of a questionnaire to assess inter-episode functioning in bipolar disorder: bipolar disorder functioning questionnaire. Turk J Psychiatry. 2007;18.
65. Rybarczyk B. Social and occupational functioning assessment scale (SOFAS). Encyclopedia of clinical neuropsychology; 2011. p. 2313.
66. Burdick KE, Ketter TA, Goldberg JF, Calabrese JR. Assessing cognitive function in bipolar disorder: challenges and recommendations for clinical trial design. J Clin Psych. 2015;76:e342.
67. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-98.
68. Borson S, Scanlan J, Brush M, Vitaliano P, Dokmak A. The mini-cog: a cognitive 'vital signs' measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry. 2000;15:1021-7.
69. Buschke H, Kuslansky G, Katz M, Stewart WF, Sliwinski MJ, Eckholdt HM, Lipton RB. Screening for dementia with the memory impairment screen. Neurology. 1999;52:231.
70. Brodaty H, Pond D, Kemp NM, Luscombe G, Harding L, Berman K, Huppert FA. The gpcog: a new screening test for dementia designed for general practice. J Am Geriatr Soc. 2002;50:530-4.
71. Shulman KI. Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry. 2000;15:548-61.
72. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal cognitive assessment, Moca: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695-9.
73. Wechsler D. Wechsler adult intelligence scale-fourth edition (WAIS-IV), vol. 22. San Antonio, TX: NCS Pearson; 2008. p. 498.
74. Wechsler D. Wechsler memory scale iv (wms-iv). In.: New York. NY: Psychological Corporation; 2009.
75. Sheslow D, Adams W. Wide Range Assessment Of Memory And Learning-Second Edition (WRAML2). Delaware: Wide range Inc; 2003.
76. Woods SP, Delis DC, Scott JC, Kramer JH, Holdnack JA. The California Verbal Learning Test-second edition: test-retest reliability, practice effects, and reliable change indices for the standard and alternate forms. Arch Clin Neuropsychol. 2006;21:413-20.
77. Benedict RH, Schretlen D, Groninger L, Brandt J. Hopkins Verbal Learning Test-Revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol. 1998;12:43-55.
78. Benedict RH, Schretlen D, Groninger L, Dobraski M, Shpritz B. Revision of the brief visuospatial memory test: studies of normal performance, reliability, and validity. Psychol Assess. 1996;8:145.
79. Rey A. L'examen psychologique dans les cas d'encéphalopathie traumatique.(les problems.). Arch Psychol (Geneve). 1941.
80. Gordon NG. The trail making test in neuropsychological diagnosis. J Clin Psychol. 1972.
81. Heaton RK. Wisconsin card sorting test manual; revised and expanded. Psychol Assess Resour. 1981:5-57.
82. Delis DC, Kramer JH, Kaplan E, Holdnack J. Reliability and validity of the Delis-Kaplan executive function system: an update. J Int Neuropsychol Soc. 2004;10:301-3.
83. Goodglass H, Kaplan E, Weintraub S: Boston naming test: Lea & Febiger; 1983.
84. Ruff R, Light R, Parker S, Levin H. Benton controlled oral word association test: reliability and updated norms. Arch Clin Neuropsychol. 1996;11:329-38.
85. Kern RS, Gold JM, Dickinson D, Green MF, Nuechterlein KH, Baade LE, Keefe RS, Mesholam-Gately RI, Seidman LJ, Lee C. The MCCB impairment profile for schizophrenia outpatients: results from the matrics psychometric and standardization study. Schizophr Res. 2011;126:124-31.
86. WHOQOL Group. The World Health Organization Quality Of Life Assessment (WHOQOL): position paper from the world health organization. Soc Sci Med. 1995;41:1403-9.
87. Michalak EE, Murray G, RTtSPIiBD C. Development of the QoL.BD: a disorder-specific scale to assess quality of life in bipolar disorder. Bipolar Disord. 2010. https://doi.org/10.1111/j.1399-5618.2010.00865.x.
88. Rabin R, Fd C. EQ-SD: a measure of health status from the EuroQol group. Ann Med. 2001;33:337-43.
89. Van Nieuwenhuizen C, Schene A, Koeter M, Huxley P. The Lancashire quality of life profile: modification and psychometric evaluation. Soc Psychiatry Psychiatr Epidemiol. 2001;36:36-44.
90. Priebe S, Huxley P, Knight S, Evans S. Application and results of the Manchester short assessment of quality of life (Mansa). Int J Soc Psychiatry. 1999;45:7-12.
91. Russo J, Roy-Byrne P, Reeder D, Alexander M, DWYER-O'CONNOR ED, Dagadakis C, Ries R, Patrick D. Longitudinal assessment of quality of life in acute psychiatric inpatients: reliability and validity. J Nerv Ment Dis. 1997;185:166-75.
92. Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, Andreasen NC. The longitudinal interval follow-up evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry. 1987. https://doi.org/10.1001/archpsyc.1987.01800180050009.
93. Ware JE Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996:220-33.
94. Ware JE, Sherbourne CD, Davies AR. Developing and testing the MOS 20-item short-form health survey. 1992.
95. McHorney CA, Ware JE Jr, Lu JR, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994:40-66.
96. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bull. 1993;29(2):321-6. https://medworksmedia.com/journals/psychopharmacology-bulletin/.
97. Hunt SM, McKenna SP. The QLDS: a scale for the measurement of quality of life in depression. Health Policy. 1992;22:307-19.
98. Ferrans CE, Powers MJ. Quality of life index: development and psychometric properties. Adv Nurs Sci. 1985.
99. Group TW. The World Health Organization Quality Of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med. 1998;46:1569-85.
100. Higgins JPT, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011. https://doi.org/10.1136/bmj.d5928.
101. Sterne JAC, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016. https://doi.org/10.1136/bmj.i4919.
102. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924.
103. Hong QN, Pluye P, Bujold M, Wassef M. Convergent and sequential synthesis designs: implications for conducting and reporting systematic reviews of qualitative and quantitative evidence. Systematic reviews. 2017. https://doi.org/10.1186/s13643-017-0454-2.
104. Dixon-Woods M, Bonas S, Booth A, Jones DR, Miller T, Sutton AJ, Shaw RL, Smith JA, Young B. How can systematic reviews incorporate qualitative research? A critical perspective. Qual Res. 2006;6:27-44.